2023
DOI: 10.1101/2023.10.02.556536
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Genetic or pharmacological inactivation of CREBBP sensitizes B-cell Acute Lymphoblastic Leukemia to Ferroptotic Cell Death upon BCL2 Inhibition

Alicia Garcia-Gimenez,
Jonathan E. Ditcham,
Dhoyazan M.A. Azazi
et al.

Abstract: B-cell acute lymphoblastic leukemia (B-ALL) is a leading cause of death in childhood and outcomes in adults remain dismal. There is therefore an urgent clinical need for therapies that target the highest risk cases. Mutations in the histone acetyltransferaseCREBBPassociate with high-risk features in B-ALL and have been implicated in chemoresistance. We performed a targeted drug screen in isogenic human cell lines, identifying a number of actionable small molecules that specifically targetCREBBP-mutated B-ALL. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 45 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?